↓ Skip to main content

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, August 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs
2 blogs
twitter
30 X users
patent
1 patent

Readers on

mendeley
98 Mendeley